Head and neck cancers, Melanoma, Sarcoma, Skin cancer, Womb (uterine or endometrial) cancer
Results
Phase 1/2
This trial was looking at a treatment called Reolysin in combination with paclitaxel and carboplatin chemotherapy for advanced cancers, including head and neck cancers.
Doctors often treat advanced cancers with paclitaxel and carboplatinchemotherapy. Researchers wanted to know if adding a drug called Reolysin would help improve the treatment outcome.
Recruitment start: 1 June 2007
Recruitment end: 30 April 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kevin Harrington
Experimental Cancer Medicine Centre (ECMC)
Oncolytics Biotech Inc.
Last reviewed: 24 Apr 2013
CRUK internal database number: 1341